Us Physicalrapy Stock Investor Sentiment
| USPH Stock | USD 98.02 0.19 0.19% |
Under 59% of US Physicalrapy's investor base is looking to short. The analysis of overall sentiment of trading US Physicalrapy stock suggests that many investors are alarmed at this time. US Physicalrapy's investing sentiment shows overall attitude of investors towards US Physicalrapy.
USPH |
US Physicalrapy Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards US Physicalrapy can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about US Physicalrapy that are available to investors today. That information is available publicly through USPH media outlets and privately through word of mouth or via USPH internal channels. However, regardless of the origin, that massive amount of USPH data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of US Physicalrapy news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of US Physicalrapy relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to US Physicalrapy's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive US Physicalrapy alpha.
US Physicalrapy Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Physical Therapy Practice | 09/03/2024 |
| US Physicalrapy dividend paid on 13th of September 2024 | 09/13/2024 |
2 | Disposition of 2900 shares by Christopher Reading of US Physicalrapy at 100.26 subject to Rule 16b-3 | 09/30/2024 |
3 | Acquisition by Kathleen Gilmartin of 600 shares of US Physicalrapy at 92.26 subject to Rule 16b-3 | 10/04/2024 |
4 | U.S. Physical Therapy, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call | 10/23/2024 |
5 | U.S. Physical Therapy Completes Acquisition of 50-Clinic Physical Therapy Practice | 10/31/2024 |
6 | Earnings To Watch US Physical Therapy Inc Reports Q3 2024 Result | 11/05/2024 |
7 | U.S. Physical Therapy Issues Earnings Results, Beats Expectations By 0.01 EPS | 11/07/2024 |
8 | US Physical Therapy Inc Q3 2024 Earnings Call Highlights Record Patient Visits and ... | 11/08/2024 |
9 | Disposition of 2000 shares by Bernard Harris of US Physicalrapy at 92.95 subject to Rule 16b-3 | 11/12/2024 |
10 | This Insider Has Just Sold Shares In U.S. Physical Therapy | 11/14/2024 |
11 | Graham D. Reeve Sells 1,724 Shares of U.S. Physical Therapy, Inc. Stock | 11/15/2024 |
12 | EULAV Asset Management Lowers Position in U.S. Physical Therapy, Inc. | 11/20/2024 |
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |